Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool May 4, 2006 Stephen D. Simpson	Aspect Won't Put You to Sleep High valuation of this med-tech company all but guarantees that the stock will see some volatility.
The Motley Fool July 27, 2005 Stephen D. Simpson	Back Pain for Shorts? Kyphon continues to defy its skeptics. A developer of minimally invasive technology for the spine, the company saw revenue in the second quarter grow 48% as the U.S. business grew about 41% and overseas sales climbed 99%. Investors, take note.
The Motley Fool July 27, 2006 Stephen D. Simpson	Growth Ingrates Dump Intuitive Surgical Despite today's sell-off, Intuitive Surgical remains a red-hot grower in the med-tech space.
The Motley Fool May 8, 2006 Stephen D. Simpson	A Firm Backbone at Kyphon Medtronic begins a lawsuit, but Kyphon should continue to grow. However, these shares are on the expensive side, even for a fast-growing med-tech company.
The Motley Fool May 5, 2006 Stephen D. Simpson	FoxHollow-ed Out Worries about guidance may be giving investors a second crack at this med-tech stock.
The Motley Fool April 20, 2006 Stephen D. Simpson	More Predictable Unpredictability at ICU Hidden beneath all of the volatility is a pretty decent med-tech business. Recent volatility was the kind that investors like. The stock spiked up as earnings exceeded analyst estimates and the business did a fair bit better than management had projected at the end of last quarter.
The Motley Fool October 19, 2005 Stephen D. Simpson	ICU, You Look Healthier An incredible third quarter shows what operating leverage can do for this little medical technology company. Investors, take note.
The Motley Fool August 4, 2006 Stephen D. Simpson	SilverHawk Flying Just Fine, Thanks With med-tech company FoxHollow Technologies, there is growth and risk in equal measure. Investors, take note.
The Motley Fool August 21, 2006 Stephen D. Simpson	Kensey Nash Losing the Benefit of the Doubt Med-tech investors won't wait indefinitely for growth. Investors can find better values in this sector if they're willing to roll up their sleeves for some due diligence.
CRM June 10, 2015	Fonolo and Aspect Partner to Bring Multichannel Call-Backs to Call Centers Fonolo joins the Aspect Technology Alliance Program.
The Motley Fool January 30, 2011 Cindy Johnson	Good News: IBM Lowers Its Standards "Uncloaking" the operating results could boost the P/E ratio and stock.
The Motley Fool August 23, 2006 Stephen D. Simpson	Is Medtronic Sweeping the Deck? Nothing's changing at a deep fundamental level in health care that would impede the growth of this giant med-tech corporation. However, investors need to proceed with caution.
The Motley Fool January 30, 2006 Stephen D. Simpson	Don't Hold Your Breath for Kensey Nash It's not over for Kensey Nash -- it will soon be seeing revenue from new partners Medtronic and Zimmer. But the stock's price continues to value this company as a growing med-tech idea.
The Motley Fool May 9, 2006 Stephen D. Simpson	NeuroMetrix Has a Lot of Nerve Though an excellent opportunity, the med-tech's price has outpaced value for investors.
The Motley Fool May 9, 2005 Stephen D. Simpson	Integra LifeSciences Strikes a Nerve The med-tech company's missed quarter coupled with some slightly disappointing guidance caused investors to lose a bit of faith, sending the shares down more than 15% at one point.
The Motley Fool January 26, 2007 Matthew Crews	Bard's Costly Quarter? The medical device company suffered from multiple one-time charges. Investors who've seen the cup as half full have fared much better here than with many other med-tech companies.
The Motley Fool July 31, 2006 Stephen D. Simpson	Kinetic Concepts Approaches a Binary Outcome The resolution of a patent infringement trial means far more than one quarter's results for this med-tech company. Investors, take note.
The Motley Fool July 3, 2006 Stephen D. Simpson	Encore Takes Final Bow Encore Medical, a med-tech company that could never quite get going, sells out to a private investor. Investors, take note.
The Motley Fool January 25, 2006 Stephen D. Simpson	Abbott Wins No matter what Boston Scientific does with Guidant, Abbott looks like a winner. This stock might not offer a rocket ride the way smaller biotechs and med-tech companies do, but at today's prices, at least you won't have to worry about a fiery re-entry.
The Motley Fool February 5, 2007 Ryan Fuhrmann	Boston Scientific's Unscientific Outlook There's still uncertainty as the med-tech company blends an acquisition and deals with controversy. Investors, take note.
The Motley Fool January 30, 2006 Stephen D. Simpson	A Bard's Tale The advanced medical technology company's stock already reflects new products' potential. Still, life in the med-tech sector could get more interesting in the coming quarters. Investors, take note.
The Motley Fool June 30, 2006 Stephen D. Simpson	Arrow's Erratic Flight Progress for the med-tech is still slow in coming, though market rewards have come faster. Investors, take note.
The Motley Fool March 9, 2005 Stephen D. Simpson	The Merits of Merit Medical Living in the gaps created by the big boys is risky for small medical device makers, but it can pay off over time. Merit Medical could hold some merit for patient value portfolios.
CRM March 14, 2014 Leonard Klie	Aspect Software Releases Workforce Optimization 8.0 and Aspect Mentor Aspect's WFO 8.0 and Aspect Mentor expand the reach of speech analytics beyond basic call recordings.
The Motley Fool September 11, 2006 Rich Smith	Smith & Wesson Pops First-quarter growth exceeded expectations, but lower parts of the income statement didn't look as strong. Investors, take note.
The Motley Fool March 2, 2005 Stephen D. Simpson	CardioDynamics' Palpitations The small-cap medical device maker has a good device, but driving growth is a bit tougher. An investment in CardioDynamics will be an exercise in patience.
InternetNews May 18, 2010	HP Beats Street on Servers, PC Strength HP tops expectations amid a sign of returning strength in the hardware market.
The Motley Fool August 2, 2006 Stephen D. Simpson	Integra the Cyborg Mediocre underlying growth is a cause for long-term concern at the med-tech company. Investors, take note.
The Motley Fool November 9, 2006 Brian Lawler	Hospira's Flatlining Sales There's no good news to be found in this medical products supplier's medicine chest. The upcoming fourth quarter isn't going to be any better, either. Investors, take note.
The Motley Fool February 6, 2007 Jean Graham	Nuance Says "Call Home" It was another losing quarter for embedded speech application developer -- at least if you like your companies to play by GAAP rules.
InternetNews April 21, 2011	EMC Q1 Revenues Grow on Customer Demand The market for storage continues to grow, propelling EMC to record revenues.
The Motley Fool August 10, 2006 Stephen D. Simpson	Volatility, Thy Name Is Hospira Margins continue to stand in the way of consistent performance at the health-care company. Investors, take note.
The Motley Fool February 8, 2005 Stephen D. Simpson	Kyphon Developing a Backbone The small med-tech company posts a rich valuation, but growth is hot, and the market is huge.
The Motley Fool April 24, 2006 Stephen D. Simpson	Kensey Nash: Now the Comeback Kid? Strong results from a new device might be reason for optimism. Investors should still keep an eye on the valuations here and err on the side of cheapness.
CRM February 24, 2012 Leonard Klie	Aspect Inks a UC Distribution Deal with Dell Dell Services will deliver Aspect's unified communications solutions for next-generation customer contact centers.